80 FR 62155 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 80, Issue 199 (October 15, 2015)
Federal Motor Carrier Safety Administration
Federal Register Volume 80, Issue 199 (October 15, 2015)
| Page Range | 62155-62161 | |
| FR Document | 2015-26243 |
[Federal Register Volume 80, Number 199 (Thursday, October 15, 2015)] [Notices] [Pages 62155-62161] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-26243] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2015-0069] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA). ACTION: Notice of applications for exemptions; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 41 individuals for exemption from the prohibition against persons with insulin-treated diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before November 16, 2015. ADDRESSES: You may submit comments bearing the Federal Docket Management [[Page 62156]] System (FDMS) Docket No. FMCSA-2015-0069 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket numbers for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The Federal Docket Management System (FDMS) is available 24 hours each day, 365 days each year. If you want acknowledgment that we received your comments, please include a self- addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Charles A. Horan, III, Director, Carrier, Driver and Vehicle Safety Standards, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-224, Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday through Friday, except Federal holidays. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the Federal Motor Carrier Safety Regulations for a 2-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the 2-year period. The 41 individuals listed in this notice have recently requested such an exemption from the diabetes prohibition in 49 CFR 391.41(b) (3), which applies to drivers of CMVs in interstate commerce. Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. II. Qualifications of Applicants David V. Bartel Mr. Bartel, 45, has had ITDM since 2014. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bartel understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bartel meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Minnesota. Derwin M. Beckles Mr. Beckles, 43, has had ITDM since 2013. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Beckles understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Beckles meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New Jersey. John H. Bell Jr. Mr. Bell, 52, has had ITDM since 2012. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds an operator's license from Florida. Robert G. Chadwick Mr. Chadwick, 58, has had ITDM since 2014. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Chadwick understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Chadwick meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds an operator's license from Utah. Brian D. Correll Mr. Correll, 45, has had ITDM since 1985. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Correll understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Correll meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist [[Page 62157]] examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Pennsylvania. Stephen V. Danczak Mr. Danczak, 37, has had ITDM since 1992. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Danczak understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Danczak meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Ohio. Thomas W. Feeley Mr. Feeley, 56, has had ITDM since 2010. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Feeley understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Feeley meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New York. Jeffrey S. Gurcik Mr. Gurcik, 47, has had ITDM since 2009. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Gurcik understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Gurcik meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that does not have diabetic retinopathy. He holds an operator's license from New Jersey. Robert Hackney, Jr. Mr. Hackney, 58, has had ITDM since 2012. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hackney understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hackney meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New Jersey. Lawrence D. Hastings Mr. Hastings, 53, has had ITDM since 2014. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hastings understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hastings meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Wisconsin. Michael P. Haun Mr. Haun, 49, has had ITDM since 1989. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Haun understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Haun meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Rhode Island. Anthony G. Hill Mr. Hill, 52, has had ITDM since 2013. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hill understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hill meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Georgia. Charles H. Hillman Mr. Hillman, 67, has had ITDM since 2012. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hillman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hillman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Oregon. Alan L. Hodge Mr. Hodge, 57, has had ITDM since 2011. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hodge understands diabetes management and monitoring, [[Page 62158]] has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hodge meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds an operator's license from Minnesota. Hans G. Horschig Mr. Horschig, 58, has had ITDM since 2012. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Horschig understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Horschig meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New Mexico. Nicholas C. Huber Mr. Huber, 23, has had ITDM since 2012. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Huber understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Huber meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Iowa. Joseph S. Hurlburt Mr. Hurlburt, 64, has had ITDM since 2013. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hurlburt understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hurlburt meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from New York. Robert J. Johnson Mr. Johnson, 30, has had ITDM since 2009. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Johnson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Johnson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Washington. Christopher E. Jones Mr. Jones, 54, has had ITDM since 2014. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Jones understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Jones meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New York. Roger L. Killion Mr. Killion, 44, has had ITDM since 2011. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Killion understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Killion meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from North Carolina. Robert L. Lawson Mr. Lawson, 36, has had ITDM since 1987. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Lawson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lawson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from South Carolina. Leroy Madison Mr. Madison, 63, has had ITDM since 2012. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Madison understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Madison meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from South Carolina. Mark L. Martin Mr. Martin, 51, has had ITDM since 2010. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the [[Page 62159]] assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Martin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Martin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Washington. Wendell J. Matthews Mr. Matthews, 54, has had ITDM since 2011. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Matthews understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Matthews meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Missouri. Peter G. Mattos Mr. Mattos, 60, has had ITDM since 2014. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Mattos understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Mattos meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds an operator's license from Vermont. Randy G. Moody Mr. Moody, 59, has had ITDM since 2007. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Moody understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Moody meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Tennessee. Michael J. Murray, Jr. Mr. Murray, 41, has had ITDM since 2015. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Murray understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Murray meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from California. Joseph K. Neisen Mr. Neisen, 31, has had ITDM since 2009. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Neisen understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Neisen meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds an operator's license from Illinois. Manuel Pereira Mr. Pereira, 61, has had ITDM since 1998. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Pereira understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Pereira meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Connecticut. Herman Powell, Jr. Mr. Powell, 58, has had ITDM since 2013. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Powell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Powell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds an operator's license from Texas. William H. Riley, Jr. Mr. Riley, 51, has had ITDM since 2012. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Riley understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Riley meets the requirements of the vision standard at 49 CFR [[Page 62160]] 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. James W. Smith Mr. Smith, 50, has had ITDM since 2015. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Smith understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Smith meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from South Carolina. Thomas H. Smith Mr. Smith, 57, has had ITDM since 2014. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Smith understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Smith meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Wisconsin. Michael J. Swanson Mr. Swanson, 58, has had ITDM since 1996. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Swanson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Swanson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Illinois. Patrick J. Sweeney Mr. Sweeney, 51, has had ITDM since 1991. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Sweeney understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Sweeney meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class B CDL from New Jersey. Richard T. Tabeling Mr. Tabeling, 79, has had ITDM since 2007. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Tabeling understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Tabeling meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds an operator's license from Kentucky. David Tellez Mr. Tellez, 51, has had ITDM since 2010. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Tellez understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Tellez meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Montana. Mark A. Turley Mr. Turley, 43, has had ITDM since 1976. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Turley understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Turley meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Kristi L. Turner Ms. Turner, 47, has had ITDM since 2000. Her endocrinologist examined her in 2015 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Turner understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Turner meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her optometrist examined her in 2015 and certified that she does not have diabetic retinopathy. She holds a Class B CDL from Texas. Jon T. Webster Mr. Webster, 54, has had ITDM since 2015. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or [[Page 62161]] more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Webster understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Webster meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Minnesota. Owen E. Whetzel Mr. Whetzel, 63, has had ITDM since 2015. His endocrinologist examined him in 2015 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Whetzel understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Whetzel meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2015 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from West Virginia. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the date section of the notice. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441).\1\ The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). --------------------------------------------------------------------------- \1\ Section 4129(a) refers to the 2003 notice as a ``final rule.'' However, the 2003 notice did not issue a ``final rule'' but did establish the procedures and standards for issuing exemptions for drivers with ITDM. --------------------------------------------------------------------------- Section 4129 requires: (1) Elimination of the requirement for 3 years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the 3-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C. 31136 (e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003 notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003 notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2015-0069 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period and may change this proposed rule based on your comments. FMCSA may issue a final rule at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2015-0069 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to the proposed rulemaking. Dated: October 7, 2015. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2015-26243 Filed 10-14-15; 8:45 am] BILLING CODE 4910-EX-P
![Federal Register / Vol. 80, No. 199 / Thursday, October 15, 2015 / Notices 62155
Background DEPARTMENT OF TRANSPORTATION 2015’’ (Pub. L. 113–235), FHWA
published a notice of intent to issue a
The FHWA’s Buy America policy in Federal Highway Administration waiver on its Web site (http://
23 CFR 635.410 requires a domestic www.fhwa.dot.gov/construction/
manufacturing process for any steel or Buy America Waiver Notification contracts/waivers.cfm?id=110) on July
iron products (including protective AGENCY: Federal Highway 20. The FHWA received no comments
coatings) that are permanently Administration (FHWA), DOT. in response to the publication. During
incorporated in a Federal-aid the 15-day comment period, FHWA
ACTION: Notice.
construction project. The regulation also conducted an additional review to
provides for a waiver of the Buy SUMMARY: This notice provides locate potential domestic manufacturers
America requirements when the information regarding FHWA’s finding of motor and machinery brakes that
application would be inconsistent with that a Buy America waiver is meet AASHTO and Florida DOT
the public interest or when satisfactory appropriate for the use of non-domestic standards. Based on all the information
quality domestic steel and iron products motor and machinery brakes for a available to the agency, FHWA
are not sufficiently available. This moveable bridge in the State of Florida. concludes that there are no domestic
notice provides information regarding DATES: The effective date of the waiver
manufacturers of motor and machinery
FHWA’s finding that a Buy America is October 16, 2015. brakes that meet the specifications.
In accordance with the provisions of
waiver is appropriate for use of non- FOR FURTHER INFORMATION CONTACT: For section 117 of the SAFETEA–LU
domestic Voith 21/R5 propulsion units questions about this notice, please Technical Corrections Act of 2008 (Pub.
to replace the existing propulsion units, contact Mr. Gerald Yakowenko, FHWA L. 110–244, 122 Stat. 1572), FHWA is
Voith 24/65, which have reached the Office of Program Administration, (202) providing this notice as its finding that
end of their useful life. 366–1562, or via email at a waiver of Buy America requirements
In accordance with Division K, gerald.yakowenko@dot.gov. For legal is appropriate. The FHWA invites
questions, please contact Mr. Jomar public comment on this finding for an
section 122 of the ‘‘Consolidated and
Maldonado, FHWA Office of the Chief additional 15 days following the
Further Continuing Appropriations Act,
Counsel, (202) 366–1373, or via email at effective date of the finding. Comments
2015’’ (Pub. L. 113–235), FHWA
Jomar.Maldonado@dot.gov. Office hours may be submitted to FHWA’s Web site
published a notice of intent to issue a for the FHWA are from 8:00 a.m. to 4:30
waiver on its Web site (http:// via the link provided to the waiver page
p.m., E.T., Monday through Friday, noted above.
www.fhwa.dot.gov/construction/ except Federal holidays.
contracts/waivers.cfm?id=112) on (Authority: 23 U.S.C. 313; Pub. L. 110–161,
SUPPLEMENTARY INFORMATION: 23 CFR 635.410).
August 18. The FHWA received no
comments in response to the Electronic Access Issued on: October 6, 2015.
publication. During the 15-day comment An electronic copy of this document Gregory G. Nadeau,
period, FHWA conducted an additional may be downloaded from the Federal Administrator, Federal Highway
review to locate potential domestic Register’s home page at: http:// Administration.
manufacturers of propulsion units that www.archives.gov and the Government [FR Doc. 2015–26190 Filed 10–14–15; 8:45 am]
are equivalent to Voith 21/R5 units. Printing Office’s database at: http:// BILLING CODE 4910–22–P
Based on all the information available to www.access.gpo.gov/nara.
the agency, FHWA concludes that there Background
are no domestic manufacturers of DEPARTMENT OF TRANSPORTATION
propulsion units that are equivalent to The FHWA’s Buy America policy in
Voith 21/R5 units. 23 CFR 635.410 requires a domestic Federal Motor Carrier Safety
manufacturing process for any steel or Administration
In accordance with the provisions of iron products (including protective
section 117 of the SAFETEA–LU [Docket No. FMCSA–2015–0069]
coatings) that are permanently
Technical Corrections Act of 2008 (Pub. incorporated in a Federal-aid Qualification of Drivers; Exemption
L. 110–244, 122 Stat. 1572), FHWA is construction project. The regulation also Applications; Diabetes Mellitus
providing this notice as its finding that provides for a waiver of the Buy
a waiver of Buy America requirements America requirements when the AGENCY: Federal Motor Carrier Safety
is appropriate. The FHWA invites application would be inconsistent with Administration (FMCSA).
public comment on this finding for an the public interest or when satisfactory ACTION: Notice of applications for
additional 15 days following the quality domestic steel and iron products exemptions; request for comments.
effective date of the finding. Comments are not sufficiently available. This
SUMMARY: FMCSA announces receipt of
may be submitted to FHWA’s Web site notice provides information regarding
applications from 41 individuals for
via the link provided to the waiver page FHWA’s finding that a Buy America
exemption from the prohibition against
noted above. waiver is appropriate for use of non-
persons with insulin-treated diabetes
domestic motor and machinery brakes
Authority: 23 U.S.C. 313; Pub. L. 110–161, mellitus (ITDM) operating commercial
that meet American Association of State
23 CFR 635.410) motor vehicles (CMVs) in interstate
Highway Transportation Officials
commerce. If granted, the exemptions
mstockstill on DSK4VPTVN1PROD with NOTICES
Issued on: October 6, 2015. (AASHTO) Moveable Highway Bridge
would enable these individuals with
Gregory G. Nadeau, Design Specifications and Florida DOT
ITDM to operate CMVs in interstate
Administrator, Federal Highway Structures Design Guidelines for the
commerce.
Administration. Flagler Memorial Bridge Replacement
Project, Palm Beach County, Florida. DATES: Comments must be received on
[FR Doc. 2015–26189 Filed 10–14–15; 8:45 am]
In accordance with Division K, or before November 16, 2015.
BILLING CODE 4910–22–P
section 122 of the ‘‘Consolidated and ADDRESSES: You may submit comments
Further Continuing Appropriations Act, bearing the Federal Docket Management
VerDate Sep<11>2014 17:19 Oct 14, 2015 Jkt 238001 PO 00000 Frm 00144 Fmt 4703 Sfmt 4703 E:\FR\FM\15OCN1.SGM 15OCN1](https://thefederalregister.org/doc/80_FR_62354/page/1.svg)
![Federal Register / Vol. 80, No. 199 / Thursday, October 15, 2015 / Notices 62161
more) severe hypoglycemic episodes in period of insulin use to demonstrate may issue a final rule at any time after
the last 5 years. His endocrinologist stable control of diabetes before being the close of the comment period.
certifies that Mr. Webster understands allowed to operate a CMV.
In response to section 4129, FMCSA V. Viewing Comments and Documents
diabetes management and monitoring,
has stable control of his diabetes using made immediate revisions to the To view comments, as well as any
insulin, and is able to drive a CMV diabetes exemption program established documents mentioned in this preamble,
safely. Mr. Webster meets the by the September 3, 2003 notice. To submit your comment online, go to
requirements of the vision standard at FMCSA discontinued use of the 3-year http://www.regulations.gov and in the
49 CFR 391.41(b)(10). His driving experience and fulfilled the search box insert the docket number
ophthalmologist examined him in 2015 requirements of section 4129 while FMCSA–2015–0069 and click ‘‘Search.’’
and certified that he does not have continuing to ensure that operation of Next, click ‘‘Open Docket Folder’’ and
diabetic retinopathy. He holds a Class B CMVs by drivers with ITDM will you will find all documents and
CDL from Minnesota. achieve the requisite level of safety comments related to the proposed
required of all exemptions granted rulemaking.
Owen E. Whetzel under 49 U.S.C. 31136 (e). Dated: October 7, 2015.
Mr. Whetzel, 63, has had ITDM since Section 4129(d) also directed FMCSA
Larry W. Minor,
2015. His endocrinologist examined him to ensure that drivers of CMVs with
in 2015 and certified that he has had no ITDM are not held to a higher standard Associate Administrator for Policy.
severe hypoglycemic reactions resulting than other drivers, with the exception of [FR Doc. 2015–26243 Filed 10–14–15; 8:45 am]
in loss of consciousness, requiring the limited operating, monitoring and BILLING CODE 4910–EX–P
assistance of another person, or medical requirements that are deemed
resulting in impaired cognitive function medically necessary.
that occurred without warning in the The FMCSA concluded that all of the DEPARTMENT OF TRANSPORTATION
past 12 months and no recurrent (2 or operating, monitoring and medical
more) severe hypoglycemic episodes in requirements set out in the September 3, Federal Motor Carrier Safety
the last 5 years. His endocrinologist 2003 notice, except as modified, were in Administration
certifies that Mr. Whetzel understands compliance with section 4129(d). [Docket No. FMCSA–2015–0055]
diabetes management and monitoring, Therefore, all of the requirements set
has stable control of his diabetes using out in the September 3, 2003 notice, Qualification of Drivers; Exemption
insulin, and is able to drive a CMV except as modified by the notice in the Applications; Vision
safely. Mr. Whetzel meets the Federal Register on November 8, 2005 AGENCY: Federal Motor Carrier Safety
requirements of the vision standard at (70 FR 67777), remain in effect. Administration (FMCSA), DOT.
49 CFR 391.41(b)(10). His optometrist
IV. Submitting Comments ACTION: Notice of final disposition.
examined him in 2015 and certified that
he does not have diabetic retinopathy. You may submit your comments and SUMMARY: FMCSA announces its
He holds a Class A CDL from West material online or by fax, mail, or hand decision to exempt 45 individuals from
Virginia. delivery, but please use only one of the vision requirement in the Federal
these means. FMCSA recommends that Motor Carrier Safety Regulations
III. Request for Comments you include your name and a mailing (FMCSRs). They are unable to meet the
In accordance with 49 U.S.C. 31136(e) address, an email address, or a phone vision requirement in one eye for
and 31315, FMCSA requests public number in the body of your document various reasons. The exemptions will
comment from all interested persons on so that FMCSA can contact you if there enable these individuals to operate
the exemption petitions described in are questions regarding your commercial motor vehicles (CMVs) in
this notice. We will consider all submission. interstate commerce without meeting
comments received before the close of To submit your comment online, go to
the prescribed vision requirement in
business on the closing date indicated http://www.regulations.gov and in the
one eye. The Agency has concluded that
in the date section of the notice. search box insert the docket number
FMCSA notes that section 4129 of the granting these exemptions will provide
FMCSA–2015–0069 and click the search
Safe, Accountable, Flexible and a level of safety that is equivalent to or
button. When the new screen appears,
Efficient Transportation Equity Act: A greater than the level of safety
click on the blue ‘‘Comment Now!’’
Legacy for Users requires the Secretary maintained without the exemptions for
button on the right hand side of the
to revise its diabetes exemption program these CMV drivers.
page. On the new page, enter
established on September 3, 2003 (68 FR DATES: The exemptions were granted
information required including the
52441).1 The revision must provide for specific section of this document to August 25, 2015. The exemptions expire
individual assessment of drivers with which each comment applies, and on August 25, 2017.
diabetes mellitus, and be consistent provide a reason for each suggestion or FOR FURTHER INFORMATION CONTACT:
with the criteria described in section recommendation. If you submit your Charles A. Horan, III, Director, Carrier,
4018 of the Transportation Equity Act comments by mail or hand delivery, Driver and Vehicle Safety Standards,
for the 21st Century (49 U.S.C. 31305). submit them in an unbound format, no (202) 366–4001, fmcsamedical@dot.gov,
Section 4129 requires: (1) Elimination larger than 81⁄2 by 11 inches, suitable for FMCSA, Department of Transportation,
of the requirement for 3 years of copying and electronic filing. If you 1200 New Jersey Avenue SE., Room
experience operating CMVs while being W64–224, Washington, DC 20590–0001.
mstockstill on DSK4VPTVN1PROD with NOTICES
submit comments by mail and would
treated with insulin; and (2) like to know that they reached the Office hours are from 8:30 a.m. to 5
establishment of a specified minimum facility, please enclose a stamped, self- p.m., Monday through Friday, except
addressed postcard or envelope. Federal holidays. If you have questions
1 Section 4129(a) refers to the 2003 notice as a
We will consider all comments and on viewing or submitting material to the
‘‘final rule.’’ However, the 2003 notice did not issue docket, contact Docket Services,
a ‘‘final rule’’ but did establish the procedures and
material received during the comment
standards for issuing exemptions for drivers with period and may change this proposed telephone (202) 366–9826.
ITDM. rule based on your comments. FMCSA SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014 17:19 Oct 14, 2015 Jkt 238001 PO 00000 Frm 00150 Fmt 4703 Sfmt 4703 E:\FR\FM\15OCN1.SGM 15OCN1](https://thefederalregister.org/doc/80_FR_62354/page/7.svg)
Document Created: 2018-02-27 08:52:42
Document Modified: 2018-02-27 08:52:42
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemptions; request for comments. | |
| Dates | Comments must be received on or before November 16, 2015. | |
| Contact | Charles A. Horan, III, Director, Carrier, Driver and Vehicle Safety Standards, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-224, Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday through Friday, except Federal holidays. | |
| FR Citation | 80 FR 62155 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR